Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Accumulated other comprehensive income (loss)	Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2022		107,673,052
Beginning balance at Dec. 31, 2022	$ 502,125	$ 108	$ 1,055,048	$ (9,557)	$ (543,474)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	35,811		35,811
Common stock issued under employee stock plans (in shares)		2,218,811
Common stock issued under employee stock plans	5,853	$ 2	5,851
Taxes paid related to net share settlement of equity awards	(16,864)		(16,864)
Repurchase of common stock (in shares)		(100,000)
Repurchase of common stock	(2,519)		(2,519)
Unrealized income (loss) on derivative instruments, net of tax	(4,980)			(4,980)
Unrealized income (loss) on available for sale securities, net of tax	156			156
Net loss	(38,304)				(38,304)
Ending balance (in shares) at Mar. 31, 2023		109,791,863
Ending balance at Mar. 31, 2023	481,278	$ 110	1,077,327	(14,381)	(581,778)
Beginning balance (in shares) at Dec. 31, 2022		107,673,052
Beginning balance at Dec. 31, 2022	502,125	$ 108	1,055,048	(9,557)	(543,474)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized income (loss) on derivative instruments, net of tax	(13,012)
Unrealized income (loss) on available for sale securities, net of tax	(551)
Net loss	(100,018)
Ending balance (in shares) at Sep. 30, 2023		108,953,058
Ending balance at Sep. 30, 2023	444,573	$ 109	1,111,076	(23,120)	(643,492)
Beginning balance (in shares) at Mar. 31, 2023		109,791,863
Beginning balance at Mar. 31, 2023	481,278	$ 110	1,077,327	(14,381)	(581,778)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	39,385		39,385
Common stock issued under employee stock plans (in shares)		233,974
Common stock issued under employee stock plans	36		36
Taxes paid related to net share settlement of equity awards	(2,575)		(2,575)
Repurchase of common stock (in shares)		(207,278)
Repurchase of common stock	(5,080)		(5,080)
Unrealized income (loss) on derivative instruments, net of tax	(2,991)			(2,991)
Unrealized income (loss) on available for sale securities, net of tax	(647)			(647)
Net loss	(38,697)				(38,697)
Ending balance (in shares) at Jun. 30, 2023		109,818,559
Ending balance at Jun. 30, 2023	470,709	$ 110	1,109,093	(18,019)	(620,475)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	32,980		32,980
Common stock issued under employee stock plans (in shares)		327,868
Common stock issued under employee stock plans	5,457		5,457
Taxes paid related to net share settlement of equity awards	(532)		(532)
Repurchase of common stock (in shares)		(1,193,369)
Repurchase of common stock	(35,923)	$ (1)	(35,922)
Unrealized income (loss) on derivative instruments, net of tax	(5,041)			(5,041)
Unrealized income (loss) on available for sale securities, net of tax	(60)			(60)
Net loss	(23,017)				(23,017)
Ending balance (in shares) at Sep. 30, 2023		108,953,058
Ending balance at Sep. 30, 2023	444,573	$ 109	1,111,076	(23,120)	(643,492)
Beginning balance (in shares) at Dec. 31, 2023		109,103,721
Beginning balance at Dec. 31, 2023	489,648	$ 109	1,142,578	(8,649)	(644,390)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	32,093		32,093
Common stock issued under employee stock plans (in shares)		2,485,389
Common stock issued under employee stock plans	6,414	$ 3	6,411
Taxes paid related to net share settlement of equity awards	(34,860)		(34,860)
Unrealized income (loss) on derivative instruments, net of tax	1,797			1,797
Unrealized income (loss) on available for sale securities, net of tax	(2,253)			(2,253)
Net loss	(40,490)				(40,490)
Ending balance (in shares) at Mar. 31, 2024		111,589,110
Ending balance at Mar. 31, 2024	452,349	$ 112	1,146,222	(9,105)	(684,880)
Beginning balance (in shares) at Dec. 31, 2023		109,103,721
Beginning balance at Dec. 31, 2023	489,648	$ 109	1,142,578	(8,649)	(644,390)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized income (loss) on derivative instruments, net of tax	4,550
Unrealized income (loss) on available for sale securities, net of tax	(282)
Net loss	(82,771)
Ending balance (in shares) at Sep. 30, 2024		112,422,071
Ending balance at Sep. 30, 2024	428,560	$ 112	1,159,990	(4,381)	(727,161)
Beginning balance (in shares) at Mar. 31, 2024		111,589,110
Beginning balance at Mar. 31, 2024	452,349	$ 112	1,146,222	(9,105)	(684,880)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	30,089		30,089
Common stock issued under employee stock plans (in shares)		590,312
Common stock issued under employee stock plans	3,378		3,378
Taxes paid related to net share settlement of equity awards	(1,748)		(1,748)
Unrealized income (loss) on derivative instruments, net of tax	(961)			(961)
Unrealized income (loss) on available for sale securities, net of tax	(559)			(559)
Common stock issued for debt conversion (in shares)		195
Common stock issued for debt conversion	6		6
Net loss	(23,948)				(23,948)
Ending balance (in shares) at Jun. 30, 2024		112,179,617
Ending balance at Jun. 30, 2024	458,606	$ 112	1,177,947	(10,625)	(708,828)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	31,931		31,931
Common stock issued under employee stock plans (in shares)		242,454
Common stock issued under employee stock plans	6,290		6,290
Taxes paid related to net share settlement of equity awards	(656)		(656)
Unrealized income (loss) on derivative instruments, net of tax	3,714			3,714
Unrealized income (loss) on available for sale securities, net of tax	2,530			2,530
Purchase of capped calls related to Convertible senior notes	(55,522)		(55,522)
Net loss	(18,333)				(18,333)
Ending balance (in shares) at Sep. 30, 2024		112,422,071
Ending balance at Sep. 30, 2024	$ 428,560	$ 112	$ 1,159,990	$ (4,381)	$ (727,161)